Glaxosmithkline | GSK - Custo de Mercadoria Vendida

Preço das Ações
52.41
Mudança Diária
-6.71 -11.35%
Mensal
-11.56%
Anual
35.25%
Q2 Previsão
53.52




Custo de Mercadoria Vendida Alterar Data
AbbVie USD 4.22B 329M 2026-03
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Bausch Health Companies USD 979M 55M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Canopy Growth CAD 53.08M 8.3M 2025-12
Corcept Therapeutics USD 2.54M 2.05M 2025-12
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
J&J USD 8.07B 103M 2026-03
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 131.22M 3.52M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Zoetis USD 743M 60M 2025-12